Cite

HARVARD Citation

    Slevin, J. et al. (n.d.). Determining the safety and feasibility of unilateral cell therapy delivery to the substantia nigra for the goal of disease modification. Parkinsonism & related disorders. pp. e14-. [Online]. 
  
Back to record